We discovered that the common acute lymphoblastic leukemia antigen, CALLA (CD1 0). was identical t o human neutral endopeptidase 3.4.24.1 1 (NEP), a Zn-binding glycoprotein with an extracellular active site capable of hydrolyzing several biologically active peptides. In this study we compare the expression of CALLA/NEP in terms of antigenic density and enzymatic activity at the cell surface and of messenger RNA (mRNA) levels on granulocytes, leukemic cells, and CALLA-transfected COS-1 cells. Mature granulocytes, the only readily available source of normal human CALLA, express relatively low but constant levels of antigen, NEP activity (3.5 pmol/min/108 cells), and mRNA. The t w o major CALLA-mRNA species of 6.5 kb and 3.8 kb, observed t o date in a variety of cells and tissues, were also found in four independent granulocyte preparations. With leukemia cell lines, a correlation was established between the density of CALLA antigen and the level of enzymatic activity (3.4 t o 21 .O pmol/min/lO' cells). This paper constitutes the first report of NEP activity on blast cells derived from patients with non-T acute lymphoblastic leukemia (ALL); the levels of activity were variable (1.5 t o OMMON ACUTE lymphoblastic leukemia antigen C (CALLA; CD10) is associated with 85% of cases of childhood leukemia, those of the pre-B phenotype, also referred to as non-T ALL.' Since our discovery* of the identity of the CALLA sequence to that of neutral endopeptidase 3.4.24.1 1 (NEP),3-7 we have demonstrated in a preliminary study that CALLA expressed at the surface of melanoma and leukemia cell lines was enzymatically active. ' We have now established a quantitative assay for the purpose of comparing the levels of NEP activity on various normal and malignant cell types and of correlating them to CALLA antigenic density and to messenger RNA (mRNA) levels whenever possible. In the current study we have assessed the level of enzymatic activity on mature granulocytes, the only readily available source of CALLA, on various leukemic cell lines and for the first time on blast cells obtained directly from patients with non-T ALL. We have also transfected the CALLA-cDNA into the transient expression system provided by COS-1 cells9-" and have obtained high levels of enzymatic activity at the surface of the transfected cells. Our results indicate that leukemic cells express a normal enzyme and in general at higher levels than normal granulocytes but at lower levels than can be achieved by transfection of the CALLA gene into COS-1 cells.
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We discovered that the common acute lymphoblastic leukemia antigen, CALLA (CD1 0). was identical t o human neutral endopeptidase 3.4.24.1 1 (NEP), a Zn-binding glycoprotein with an extracellular active site capable of hydrolyzing several biologically active peptides. In this study we compare the expression of CALLA/NEP in terms of antigenic density and enzymatic activity at the cell surface and of messenger RNA (mRNA) levels on granulocytes, leukemic cells, and CALLA-transfected COS-1 cells. Mature granulocytes, the only readily available source of normal human CALLA, express relatively low but constant levels of antigen, NEP activity (3.5 pmol/min/108 cells), and mRNA. The t w o major CALLA-mRNA species of 6.5 kb and 3.8 kb, observed t o date in a variety of cells and tissues, were also found in four independent granulocyte preparations. With leukemia cell lines, a correlation was established between the density of CALLA antigen and the level of enzymatic activity (3.4 t o 21 .O pmol/min/lO' cells). This paper constitutes the first report of NEP activity on blast cells derived from patients with non-T acute lymphoblastic leukemia (ALL); the levels of activity were variable (1.5 t o OMMON ACUTE lymphoblastic leukemia antigen C (CALLA; CD10) is associated with 85% of cases of childhood leukemia, those of the pre-B phenotype, also referred to as non-T ALL.' Since our discovery* of the identity of the CALLA sequence to that of neutral endopeptidase 3.4.24.1 1 (NEP), [3] [4] [5] [6] [7] we have demonstrated in a preliminary study that CALLA expressed at the surface of melanoma and leukemia cell lines was enzymatically active. ' We have now established a quantitative assay for the purpose of comparing the levels of NEP activity on various normal and malignant cell types and of correlating them to CALLA antigenic density and to messenger RNA (mRNA) levels whenever possible. In the current study we have assessed the level of enzymatic activity on mature granulocytes, the only readily available source of CALLA, on various leukemic cell lines and for the first time on blast cells obtained directly from patients with non-T ALL. We have also transfected the CALLA-cDNA into the transient expression system provided by COS-1 cells9-" and have obtained high levels of enzymatic activity at the surface of the transfected cells. Our results indicate that leukemic cells express a normal enzyme and in general at higher levels than normal granulocytes but at lower levels than can be achieved by transfection of the CALLA gene into COS-1 cells.
MATERIALS AND METHODS
Peripheral blood samples (60 mL) were depleted of erythrocytes by 1 g sedimentation through dextran T500, and the mononuclear cell fractions were recovered by FicollHypaque gradient centrifugation and washings in phosphatebuffered saline (PBS). The granulocyte fractions were depleted of red blood cells (RBCs) by NH,Cl lysis at 37OC for 15 minutes and washed several times in RPMI medium. These cells were used immediately for flow cytometry, enzymatic activity, and/or RNA preparation.
Patient leukemic cell samples were provided by the members of the Division of Hematology-Oncology at the Hospital for Sick Cells and cell lines. 35 .9 pmol/min/108 cells for six cases) but correlated with the level of CALLA assessed by flow cytometry. Heterogeneous levels of expression of the CALLA-mRNA species were also observed in non-T ALL cases that correlated with the level of CALLA expression at the surface of these cells. Very high levels of NEP activity were achieved by transfecting COS-1 cells with pSV-CALLA; 20% of the transfected cells were CALLA+ and expressed 550 pmol/ min/108 cells. Extracts prepared from COS-1 cells transfected with pSV-CALLA (carrying human NEP cDNA) and pSVENKl9 (carrying rabbit NEP-cDNA). respectively, gave Michaelis constant (K, ) values of 50 pmol/L and similar inhibition curves with thiorphan. Thus the recombinant proteins encoded by these t w o genes have similar enzymatic properties, confirming the high degree of their structural relatedness. The expression of high levels of CALLA/NEP on COS-1 cells should allow the use of this system t o test the effects of specific mutations on activity and might lead t o the understanding of the role of CALLA in the onset and/or progression of leukemia. 0 1990 by The American Society of Hematology.
Children, Toronto, Canada. All samples were taken from bone marrow or peripheral blood of patients at the time of diagnosis and contained >75% blasts. The cell lines HYON, HOON, NALM-6, and DAUDI have been described previ~usly.~*~**'~ The A1 line was established from CALLA-lymphoblasts (HLA-DR+, CD19+) of a non-T ALL patient in relapse (Freedman et al, The Hospital for Sick Children, unpublished data, August 1987). All DNA manipulations were performed using described procedure~.'~J~ The construction of vector pSV-ENK19, which contains all the rabbit neutral endopeptidase coding sequences downstream of the SV40 early promoter, has been described." Vector pSVP4 was derived from vector pSVP3, a plasmid containing the proopiomelanocortin coding sequence," by deleting the latter sequences This digestion released all of the CALLA coding sequences preceded by 80 nucleotides of the 5' untranslated region (HueII site) and followed by 282 nucleotides of the 3' untranslated region (AccI site). This DNA fragment was then ligated into the PvuI site of pSVP4 using PvuI/HueII and PvuI/AccI adaptors. The proper orientation of the DNA fragment was verified by restriction nuclease mapping.
In this vector the expression of CALLA is under the control of the SV40 early promoter, and the transcription termination and polyadenylation signals are provided by the SV40 sequences. Plasmid DNA was prepared and transfected into COS-1 as a calcium phosphate precipitate according to published procedures.'-' Cells were harvested 40 to 43 hours following transfection using Ca2+/Mg2+ free PBS with 4mmol/L EGTA, washed twofold in Ca2+/MgZ+ free PBS and threefold in phosphate-buffered saline (PBS), since the NEP enzymatic activity is destroyed by trypsin release. Intact cells were then assayed immediately by flow cytometry and fluorimetric NEP determination. In other experiments recombinant proteins were solubilized from transfected cells directly into Tris-buffered saline containing 1% octylglucoside, as previously described'' and tested by radiometric NEP assay.
Cells ( 5 x lo5) were stained with saturating amounts of the anti-CALLA MAb 44C10" or J5 (Coulter) and FITC-conjugated F(ab'),-goat antimouse IgG (Tago Laboratories, Burlingame, CA). Samples were run on the Epics Profile Analyzer (Coulter Electronics, Hialeah, FL) using 1400 V for fluorescence Flow cytometiy. Table 1 for ALL patients were generated on an Epics V Flow Cytometer under different calibration conditions. These RFI values are also linear and expressed relative to that of the isotype-matched controls but cannot be compared to those observed with the Epics Analyzer.
DNA and RNA were prepared from leukemic cells by modification of a previous method." Following Northern blot unulysis. 6.5-3.8-
1.8-

RESULTS
The expression of CALLA and neutral endopeptidase activity is restricted to the mature granulocyte fraction of normal peripheral hlood. Normal peripheral-blood mononuclear cells do not express detectable levels of CALLA antigen on their surface. However. a recent article has suggested the presence of low but significant levels of NEP activity in membrane preparations from normal B, T, and macrophages." To clarify this issue, normal peripheral-blood mononuclear cells were characterixd phenotypically by Row cytometry prior to a s . . i n g their NEP activity. The monocyte fraction, as defined by light scattering. contained >90% MO-1-and MO-2-positive cells, while the lymphoid fraction contained on average 88% CD2' cells and 7% CD19" cells; these cell suspensions did not contain detectable levels of CALLA antigen as asses.. by flow cytometry. Table I indicates that these mononuclear cell suspensions, when assayed as intact cells. had no significant NEP activity. Thus phenotypically well-characterized lymphocyte and monocyte populations do not express detectable levels of CALLA antigen or NEP activity.
Refore the discovery of the identity of CALLA and NEP, granulocytes of peripheral blood had been reported independently to express CALLA antigen"^" and neutral endopeptidase
In the currcnt study we assesJtd on the same granulocyte populations the expression of CALLA/ NEP at the level of antigenicdensity. enzymatic activity. and mRNA levels. Granulocyte fractions of peripheral blood contained on average 99% MO-I cells ( 
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A samples is specific. a s it is inhibited by 5 rmol/L thiorphan ( Table I ).
The expression of CALLA/NEP mRNA appears equivalent in t h w four granulocyte preparations (Fig 2) and suggests a correlation between the amount of RNA and the amount of CALLA estimated at the cell surface. The two major species of mRNA of 6.5 kband 3.8 kb. associated with CALLA in kidney and leukemic cell^,?^^^' are also observed for the four granulocyte preparations. This finding disputes the previous observation of the prcsence of only the 6.5-kb mRNA species in granulocytes! A blood sample obtained from a patient 3 weeks after a liver transplant contained a high number of granulocytes of lower density on the Ficoll-Hypaquc gradient. T h w morphologically immature granulocytes (myelocytes. metamyelocyte. and bands) were 100'?6 Mo-I * and Mo-2 but were devoid of CALLA; they also expressed no N E P activity. Thus. CALLA/NEP is associated with granulocytes of mature phenotype.
Correlation between amount of CALLA and neutral endopeptidase activity expressed at the cell surface. Cell lines of leukemia and lymphoma origin were chosen for this quantitative study. since it required larger number of cells than those available from patients. Figure 3A illustrates the flow cytometry histograms obtained from five l i n e expressing increasing amounts of CALLA. Figure 3B reveals that these same cells express increasing levels of neutral endopep tidase activity. which ranged from 0.75 to 21 pmol/min/l@ cells; all cell lines were tested three times and at three different cell concentrations with and without the specific inhibitor. and mean values are illustrated. The A I cell line is negative for both CALLA antigen and N E P activity, while the NALM-6 line has the highest surface expression and activity of CALLAINEP.
Leukemic cells derived from non-T ALL patients express
NEP activity. Viable cells from six patients with non-T ALL, isolated and tested immediately or recovered by thawing of pmiously froren samples. were assayed for (Table 1) . Patient 2, of non-T ALL group I1 (defined as HLA-DR+, CD19+, and CALLA-) had no detectable NEP activity (Fig 4 and Table 1 ). Case 4, which expressed the highest level of NEP activity (35.9 pmol/min/106 cells), is a non-T ALL group IV (HLA-DR+, CD19+, CALLA+, CD20+). Patient 11 belongs to group I11 (HLA-DR+, CD19+, CALLA+), while patients 12, 13, and 14 belong to group IV. Except for patient 4, with no RFI value available, a linear correlation was observed between the level of NEP activity and the CALLA surface density assessed by flow cytometry (Table 1) . These results suggest that leukemic cells express a normal NEP whose activity is heterogeneous from patient to patient, as is the CALLA surface density.
CALLA mRNA transcripts present in non-T ALL patients. All samples derived from patients belonging to the subgroups I11 and IV (CALLA-positive cases) express the major mRNA species of 3.8 kb and 6.5 kb associated with CALLA/NEP2.6.8; the transcripts found in the leukemic cell lines HOON and NALM-6 are also illustrated in Fig 4. The level of CALLA mRNA in non-T ALL patients is heterogeneous and appears to correlate with the surface expression of CALLA. Sample 1, which showed very low intensity hybridizing bands, contained only 12% CALLA+ cells with low levels of fluorescence; samples 2 and 3 (and the EBVtransformed B cell line), which showed no mRNA transcripts, were CALLA-cells. The level of CALLA antigenic density seen on cells from patients 6, 9, and 10 (mean fluorescence values of 37, 5, and 53, respectively) follows a A pSV-control DNA pSV-CALLA trend of medium, low, and high intensity with respect to RNA levels if one takes into account the overloading of lane 10 seen with the &actin probe (Fig 4) . Because of the availability of such a low number of leukemic cells from a given patient sample, it is very difficult to perform correlation studies of CALLA expression at RNA, protein, and enzymatic activity levels. Our data certainly indicate that CALLA-negative cases studied to date do not express CALLA-mRNA and that all CALLA-positive cases show the same mRNA species.
The heterogeneous expression of CALLA in non-T ALL and the high levels observed in several cases prompted us to investigate whether the number of gene copies was normal in those patients. Using a 1.6-kb CALLA cDNA probe, no difference in the intensity of hybridization was found between EcoRI digests of DNA from CALLA-leukemic patient cells and those expressing varying amounts of CALLA/NEP (data not shown). Thus high levels of CALLA seen in several non-T ALL patient samples are not due to an increased gene-copy number.
Expression of high levels of CALLA/NEP on the surface of COS-I cells transfected with pSV-CALLA. The cDNA coding for the complete primary sequence of CALLA/NEP2 was introduced into an SV40-derived expression vector ( and express enzymatic activity on their surface, then the specific NEP activity on these cells was 550 pmol/min/106 cells. This value is 16-fold greater than observed for the highest ALL case shown in Table 1 and 26-fold that seen on NALM-6 cells (Fig 3) .
Comparative activity of recombinant human and rabbit neutral endopeptidases. NEP is known to hydrolyze specifically the Gly3-Phe4 bond of the opoid pentapeptides met-or le~-enkephalins?~,~~ To compare the activity of human and rabbit NEP toward the leu-enkephalin substrate, monolayers of COS-1 cells were transfected with pSV-CALLA, pSV-ENK19 (expressing the rabbit NEP cDNA)," or the control plasmid pSV4." Cells were extracted with octyl-glucoside 40 hours later and the activity of the soluble extracts assayed using the [3H] -Tyr-D-Ala-Leu-enkephalin substrate analogue. Hydrolysis of the substrate was only observed in the transfected cells containing the human or rabbit NEP cDNA and not in the pSV4 control cells. To further characterize the two recombinant proteins, the Km value for each enzyme was determined, and their sensitivity to inhibition by thiorphan was compared. Eadie-Hofstee plots were used to calculate the Km values; 52 pmol/L and 53 pmol/L were determined for human and rabbit NEP respectively (Fig 6A) . Furthermore, the dose-response curves obtained for the inhibition of activity by thiorphan were very similar with IC,, values of 9 and 11 nmol/L for recombinant human and rabbit enzymes respectively (Fig 6B) , in agreement with previous results?'+29 These observations suggest that the recombinant proteins encoded by the human CALLA/NEP cDNA and the rabbit NEP cDNA have similar enzymatic activities.
DISCUSSION
Previous experiments have established that following transfection of pSV-ENK cDNA in COS-1 cells, high levels of recombinant rabbit kidney neutral endopeptidase were observed with biochemical and catalytic properties identical to the native enzyme.'' Furthermore, by site-directed mutagenesis and transfection into COS-1 cells, residues essential for activity were demonstrated.11.29-31 Transfection of the human CALLA-cDNA isolated from NALM-6 cells into the murine myeloma line 5558 led to the expression of specific NEP a~tivity.~' However these transfectants expressed twofold to 10-fold less NEP activity than NALM-6 cells, and no kinetic parameters were provided for the recombinant en~yme.'~ In the current study we observed on COS-1 cells transfected with human kidney CALLA-cDNA levels of activity 26 times higher than on NALM-6 cells. The enzymatic properties of recombinant human and rabbit neutral endopeptidases were identical; the polypeptide structure of these two proteins is 95% identical: indicative of a highly conserved sequence throughout evolution. Expression of high levels of either of these two recombinant proteins into COS-1 cells, in normal or mutated forms, should permit the identification of the functional domains necessary for surface expression and enzymatic activity. These genes could then be introduced into host cells such as normal murine or human bone marrow to test the ability of enzymatically intact and mutated forms of CALLA to alter B-cell differentiation.
The current study confirms that in normal peripheral blood, mature granulocytes are the only cells expressing detectable levels of CALLA/NEP mRNA species and on their surface CALLA antigen and specific neutral endopeptidase activity. Patients with thermal injury showed several neutre phi1 defects and contained reduced numbers of CALLA' m ulocytes in their peripheral blood, which was attributed to an insacient time for maturation of the neutrophils in the marrow of these patient^.^' The CALLA-granulocytes reported here in the peripheral blood of a post liver transplant patient also likely represent immature populations of granulocytes less able to carry out chemotactic f~n~t i o n s .~~~~~*~~.~~ CALLA/ NEP can hydrolyze chemotactic thereby inhibiting its effects on mature granulocytes.
Two major mRNA species of 6.5 and 3.8 kb are associated with CALLA/NEP, as demonstrated previously for leukemic and melanoma cell lines and for normal These two mRNA species were also observed in all four granulocyte preparations tested. This finding does not support the previous observation of the absence of the 3.8-kb mRNA species in one case of granulocytes studied nor the idea of tissuespecific differential expression of these two CALLA mRNA species6 Analysis of a much larger number of CALLA' granulocyte preparations should clarify this point.
In lymphoblasts of non-T ALL patients, the same CALLAmRNA species were also found; all normal and malignant cells tested to date in our laboratory have contained these two major mRNA species. The cDNA sequence of CALLA from the leukemic cell line NALM-6 was identical to that isolated from human k i d n e~,~.~.~ supporting the idea of a normal CALLA gene product in leukemic cells.
Normal lymphocytes and monocytes do not express significant amounts of CALLA or NEP. The recent description of low levels of NEP activity in membrane preparations from normal B, T, and macrophages" did not include the immunologic phenotype of the cell populations tested. The current study revealed complete concordance between surface expression of CALLA determined by flow cytometry and thiorphaninhibitable NEP activity on intact cells. Using multiparameter flow cytometry, the frequency of CALLA+ cells has been estimated at 1 x peripheral blood mononuclear cells3'; it is thus unlikely that NEP activity could be detected in these fractions. However, populations enriched in B-cell precursors from adult bone marrow or fetal tissues and containing 1% to 10% CALLA+ cell^^^"^ should demonstrate NEP activity.
This article constitutes the first report of NEP activity on intact leukemic blasts and of mRNA transcripts in cells derived from patients with ALL. A preliminary study has demonstrated thiorphan inhibitable activity in membranes of leukemic blasts of two ALL patients. 40 Our results show heterogeneity of enzymatic activity and mRNA expression in non-T ALL patients of groups 111 and IV. These data agree with our previous studies demonstrating highly variable expression of CALLA (RFI values ranging from 2 to 79; scale of Table 1 ) on 48 cases of non-T ALL, groups I11 and IV.4' Furthermore, leukemic cells can express high levels of enzymatic activity, suggesting that no deleterious posttranslational modifications of CALLA have occurred in these cells.
What are the functional implications of NEP activity in leukemic cells? NEP can cleave several peptides, including enkephalins, bradykinin, substance P, neurotensin, angiotensins, and natriuretic peptides, leading to inactivation of their respective biological Some of these peptides and/or as yet unidentified substrates might exert regulatory activities on leukemic cells. The hydrolysis of the substrates available to the leukemic blasts in bone marrow and/or peripheral blood of patients could alter the progression of the leukemia and could even lead to an altered systemic neuroendocrine balance. Alternatively, the presence of CALLA/ NEP on leukemic cells of pre-B phenotype might reflect the necessity of cells at early stages of B lineage to express this enzymatic function to inactivate a regulatory peptide and to facilitate a differentiation event.34 The identification of the substrates hydrolyzed by CALLA/NEP in vivo in the human bone marrow should permit the elucidation of the role of this molecule in normal and malignant hematopoietic cells. For personal use only. on October 23, 2017 . by guest www.bloodjournal.org From
